Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2003, p. 4876-4878, Vol. 41, No. 10
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.10.4876-4878.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, Faculty of Medicine, University of Zaragoza, 50009 Zaragoza, Spain
Received 2 May 2003/ Returned for modification 9 June 2003/ Accepted 11 July 2003
Forty-six Yersinia enterocolitica O:3 clinical isolates resistant to nalidixic acid were studied. The use of molecular typing techniques, other indicators of resistance patterns, the plasmid profile, and the presence of genes that encode aminoglycoside-modifying enzyme production suggested to us a clonal dissemination of the studied strains.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|